Document is current
Any future updates will be listed below
-
Authors
Mu, Fangxiang
Cai, Zhuhua
Du, Lirong
Zeng, Xianghui
Zhou, Qi
Chen, Yaolong
Wang, Fang
-
Funding
Funding for this research was provided by:
Science Foundation of Lanzhou University Second Hospital (YJS-BD-19)
Medical Innovation and Development Project of Lanzhou University (lzuyxcx-2022-137)
- License Information
-
More Information
Article History
Received: 13 May 2024
Accepted: 28 June 2025
First Online: 14 July 2025
Declarations
:
: According to the Declaration of Helsinki, the protocol obtained approval from the Lanzhou University Second Hospital (2023A-530) and was registered in the Chinese Clinical Trial Registry (ChiCTR2300077436) prior to the study’s initiation. The principal investigator will strive to draft the informed consent form and supporting documents in simple language to obtain informed consent from patients and their legally authorized representatives. No study procedures will be performed until written informed consent is provided. The clinical findings of this trial will be compiled into a manuscript for presentation at scientific conferences or publication in scientific journals following the completion of the trial. The manuscript will be discussed and approved by all principal investigators of the centers involved in the study.
: N/A.
: The authors declare that they have no competing interests.
